Ian Stoll

Ian Stoll

Auto-generated profile, based on publicly available information

Ian Stoll

Department of Pathobiology and Integrative Biomedical Sciences, College of Veterinary Medicine, University of Missouri

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2024 in Ecology and Evolution
Verified
Journal Article
Open access
MPMarco Ponce
Marco Ponce
JMJacqueline M. Maille
Jacqueline M. Maille
ISIan Stoll
Ian Stoll
AJAvery James
Avery James
ABAlexander Bruce
Alexander Bruce
William MorrisonWilliam Morrison
William Morrison
Understanding the ability of internal‐ and external‐infesting stored product insects to vector microbes is important for estimating the relative risk that insects pose to postharvest commodities as they move between habitat patches and in the landscape. Thus, the aim of the current study was to evaluate and compare the microbial growth in novel food patches at different dispersal periods by different populations of Sitophilus oryzae (e.g., internal‐infesting) and Lasioderma serricorne (e.g., external‐infesting). Adults of both species collected from laboratory colonies or field‐captured populations were either placed immediately in a novel food patch, or given a dispersal period of 24 or 72 h in a sterilized environment before entering a surrogate food patch. Vectored microbes in new food patches were imaged after 3 or 5 days of foraging, and microbial growth was processed using ImageJ while fungal species were identified through sequencing the ITS4/5 ribosomal subunit. We found that increasing dispersal time resulted in multiple‐fold reductions in microbial growth surrogate food patches by L. serricorne but not S. oryzae. This was likely attributable to higher mobility by S. oryzae than L. serricorne. A total of 20 morphospecies were identified from 13 genera among the 59 sequences, with a total of 23% and 16% classified as Aspergillus and Penicillium spp. Our data suggest that there is a persistent risk of microbial contamination by both species, which has important food safety implications at food facilities.

16 December 2025 in Infection and Immunity
Verified
Journal Article
Open access
PLPerle Latré de Laté
Perle Latré de Laté
ISIan M. Stoll
Ian M. Stoll
JFJonathan Ferm
Jonathan Ferm
SMSwetha Madesh
Swetha Madesh
DFDominica Ferm
Dominica Ferm
RGRoman Ganta
Roman Ganta
Rocky Mountain spotted fever (RMSF) caused by Rickettsia rickettsii is the most fatal tick-borne disease in people and dogs in the Americas. This pathogen is transmitted by several hard ticks: Dermacentor species, Rhipicephalus sanguineus , and Amblyomma americanum . RMSF can quickly progress to a life-threatening illness with fatalities ranging from 30% to 80%. Doxycycline is the only treatment option, and currently, no methods are available to prevent RMSF. We previously reported that vaccination with R. rickettsii whole cell antigen vaccine (WCAV) with Montanide gel adjuvant offers protection against virulent R. rickettsii infection in dogs. Here, we compared three adjuvants to optimize the safety and immunogenicity of WCAV: Alhydrogel, Montanide, and Quil A. Independent of adjuvants, all vaccinees were protected, whereas unvaccinated dogs developed the clinical disease. Vaccination reduced the pathogen to undetectable levels in blood and various tissues. An R. rickettsii- specific IgG response was observed following primary vaccination in all vaccinated groups, which augmented after booster. The vaccine with Quil A had the highest IgG response with a significant rise in CD4 + and CD8 + T cell numbers, while Montanide and Alhydrogel resulted in a balanced IgG response. IgG2 was the primary antibody detected in unvaccinated infection controls. Several systemic proinflammatory cytokines varied after infection in both vaccinees and controls. Plasma concentration of intercellular adhesion molecule 1 was higher in unvaccinated compared to vaccinees in the first 9 days after infection. This study demonstrates that the WCAV efficacy is independent of the adjuvant, although Quil A induced a higher IgG response and expansion of CD4 and CD8 T cells.

15 June 2024 in Vaccine
Verified
Journal Article
Closed access
JFJonathan Ferm
Jonathan Ferm
DJDeborah C. Jaworski
Deborah C. Jaworski
ISIan Stoll
Ian Stoll
MKMichael D. Kleinhenz
Michael D. Kleinhenz
KKKatherine M. Kocan
Katherine M. Kocan
RGRoman Ganta
Roman Ganta